Treating restless legs syndrome - Where's the evidence?

Annals of Long-Term Care

Volumn 13, Issue 6, 2005, Pages 30-32

  Cooper, James ^a   Cooper, Diane ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PERGOLIDE; ROPINIROLE; ROTIGOTINE; VALPROIC ACID;

BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL; COCHRANE LIBRARY; EVIDENCE BASED MEDICINE; GERIATRIC CARE; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDLINE; PRACTICE GUIDELINE; PREVALENCE; RESTLESS LEGS SYNDROME; REVIEW;

EID: 20544444009     PISSN: 15247929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
2. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology 2004; 63:1065-1069.
3. The Merck Manual. Beers MH, Berkow R, eds. Whitehouse Station, NJ: Merck & Co., Inc.; 1999: 1416.
4. The Cochrane Library. Available at: http://www. cochrane.org. Accessed April 10, 2005.
5. Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services. London, England: Nuffield Provincial Hospitals Trust; 1972.
6. Bandolier. Available at: http://www.ebandolier. com. Accessed April 10, 2005.
7. Trenkwalder C, Hundemer HP, Lledo A, et al; PEARLS Study Group. Efficacy of pergolide in treatment of restless legs syndrome: The PEARLS Study. Neurology 2004;62(8):1391-1397.
8. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study. Neurology 2002;59(10):1573-1579.
9. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al; Therapy with Ropinirole, Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: Results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75(1):92-97.
10. National Guideline Clearinghouse. Available at: http://www.guideline.gov. Accessed March 21, 2005.
11. PubMed. Available at: http://www.pubmed.gov. Accessed March 21, 2005.
12. Bliwise DL, Freeman A, Ingram CD, et al. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome. Sleep Med 2005;6(2):141-147.
13. Stiasny-Kolster K, Kohnen R, Schollmayer E, et al; Rofigotine Sp 666 Study Group. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double-blind, placebo-controlled pilot study. Mov Disord 2004;19(12):1432-1438.
14. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. J Neurol 2004;251(5):579-583.
15. SUMSearch. Available at: http://sumsearch. uthscsa.edu. Accessed April 10, 2005.
16. Centre for Reviews and Dissemination DARE database. Available at: http://www.york.ac.uk/inst/ crd/darehp.htm. Accessed March 21, 2005.
17. Clinical Evidence. Available at: http://www. clinicalevidence.com. Accessed March 21, 2005.
18. The Merck Manual of Geriatrics. Beers MH, Berkow R, eds. Whitehouse Station, NJ: Merck & Co., Inc.; 2000:459.